Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer

Medical Oncology

Volumn 24, Issue 3, 2007, Pages 308-311

  Misirlioglu, Cem H ^a   Demirkasimoglu, Taciser ^a   Kucukplakci, Bulent ^a   Sanri, Ergun ^a   Altundag, Kadri ^b  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alpha tocopherol; Lung cancer; Pentoxifylline; Radiation induced lung toxicity

Indexed keywords

ALPHA TOCOPHEROL; PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; LUNG SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-TOCOPHEROL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; PENTOXIFYLLINE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VOMITING;

EID: 36248992380     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0006-z     Document Type: Article

References (17)

1. McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-203.
2. Robnett TJ, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000;48:89-94.
3. Inoue A, et al. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 2001;49:649-55.
4. Ozturk B, Egehan I, Atavci S, Kitapci M. Pentox?fylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 2004;58:213-9.
5. Rosen II, et al. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer. Radiology 2001;221:614-22.
6. Rube CE, et al. Modulation of radiation-induced tumour necrosis factor a (TNF-a) expression in the lung tissue by pentoxifylline. Radiother Oncol 2002;64:177-88.
7. Delanian S, Lefaix J-L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004;73:119-31.
8. Dion MW, et al. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 1990;19:401-7.
9. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 1999;17:3283-90.
10. Lefaix JL, et al. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 1999;43:839-47.
11. Dion MW, Hussey DH, Osborne JW. The effect of pentoxiflylline on early and late radiation injury following fractionated irradiation in C3H mice. Int J Radiat Oncol Biol Phys 1989;17:101-7.
12. Futran ND, Trotti A, Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope 1997;107:391-5.
13. Chua DT, Lo C, Yuen J, Foo YC. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 2001;24:366-9.
14. Aygenc E, et al. Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study. Otolaryngol Head Neck Surg 2004;130:351-6.
15. Delanian S, Porcher R, Balla-Mekias S, Lefaix J-L. Randomized placebo-controlled trial combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003;21:2545-50.
16. Makimoto T, et al. Risk factors for severe radiation pneumonitis in lung cancer. Jpn J Clin Oncol 1999;29:192-7.
17. Miller KL, Shafman TD, Marks LB. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin Radiat Oncol 2004;14:298-307.